Neutralase heparinase I: Began dose-escalation, Phase I trial in the U.K. to assess safety and pharmacokinetics in 20 healthy volunteers

IBEX Technologies Inc.,

Read the full 36 word article

How to gain access

Continue reading with a
two-week free trial.